These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 29563547)
1. The Effect of Obesity on the Availabilities of Dopamine and Serotonin Transporters. Nam SB; Kim K; Kim BS; Im HJ; Lee SH; Kim SJ; Kim IJ; Pak K Sci Rep; 2018 Mar; 8(1):4924. PubMed ID: 29563547 [TBL] [Abstract][Full Text] [Related]
2. Effects of rs591323 on serotonin transporter availability in healthy male subjects. Pak K; Nam HY; Shin S; Kim K; Lee MJ; Kim EJ; Lee JM; Kim SJ; Kim IJ Ann Nucl Med; 2018 Aug; 32(7):431-436. PubMed ID: 29774458 [TBL] [Abstract][Full Text] [Related]
3. Striatal DAT and extrastriatal SERT binding in early-stage Parkinson's disease and dementia with Lewy bodies, compared with healthy controls: An Joling M; Vriend C; Raijmakers PGHM; van der Zande JJ; Lemstra AW; Berendse HW; Booij J; van den Heuvel OA Neuroimage Clin; 2019; 22():101755. PubMed ID: 30884365 [TBL] [Abstract][Full Text] [Related]
4. Serotonin transporters in dopamine transporter imaging: a head-to-head comparison of dopamine transporter SPECT radioligands 123I-FP-CIT and 123I-PE2I. Ziebell M; Holm-Hansen S; Thomsen G; Wagner A; Jensen P; Pinborg LH; Knudsen GM J Nucl Med; 2010 Dec; 51(12):1885-91. PubMed ID: 21078806 [TBL] [Abstract][Full Text] [Related]
5. Analysis of Extrastriatal Joling M; Vriend C; van den Heuvel OA; Raijmakers PGHM; Jones PA; Berendse HW; Booij J J Nucl Med; 2017 Jul; 58(7):1117-1123. PubMed ID: 27856628 [No Abstract] [Full Text] [Related]
6. Altered serotonin and dopamine transporter availabilities in brain of depressed patients upon treatment with escitalopram: A [123 I]β-CIT SPECT study. Rominger A; Cumming P; Brendel M; Xiong G; Zach C; Karch S; Tatsch K; Bartenstein P; la Fougère C; Koch W; Pogarell O Eur Neuropsychopharmacol; 2015 Jun; 25(6):873-81. PubMed ID: 25819144 [TBL] [Abstract][Full Text] [Related]
7. Extrastriatal binding of [¹²³I]FP-CIT in the thalamus and pons: gender and age dependencies assessed in a European multicentre database of healthy controls. Koch W; Unterrainer M; Xiong G; Bartenstein P; Diemling M; Varrone A; Dickson JC; Tossici-Bolt L; Sera T; Asenbaum S; Booij J; Kapucu OL; Kluge A; Ziebell M; Darcourt J; Nobili F; Pagani M; Hesse S; Vander Borght T; Van Laere K; Tatsch K; la Fougère C Eur J Nucl Med Mol Imaging; 2014 Oct; 41(10):1938-46. PubMed ID: 24806112 [TBL] [Abstract][Full Text] [Related]
8. Effect of sex on aging-related decline of dopamine transporter in healthy subjects. Shin S; Nam HY; Lee MJ; Pak K; Kim K; Kim IJ Ann Nucl Med; 2021 Jan; 35(1):76-82. PubMed ID: 33052524 [TBL] [Abstract][Full Text] [Related]
9. Test-retest reproducibility of extrastriatal binding with Matsuoka K; Yasuno F; Shinkai T; Miyasaka T; Takahashi M; Kiuchi K; Kosaka J; Inoue M; Kichikawa K; Hasegawa M; Kishimoto T Psychiatry Res Neuroimaging; 2016 Dec; 258():10-15. PubMed ID: 27814458 [No Abstract] [Full Text] [Related]
10. Serotonin Transporter Binding in the Diencephalon Is Reduced in Insulin-Resistant Obese Humans. Versteeg RI; Koopman KE; Booij J; Ackermans MT; Unmehopa UA; Fliers E; la Fleur SE; Serlie MJ Neuroendocrinology; 2017; 105(2):141-149. PubMed ID: 27626923 [TBL] [Abstract][Full Text] [Related]
11. Serotonergic deficits in dementia with Lewy bodies with concomitant Alzheimer's disease pathology: An van der Zande JJ; Joling M; Happach IG; Vriend C; Scheltens P; Booij J; Lemstra AW Neuroimage Clin; 2020; 25():102062. PubMed ID: 31790878 [TBL] [Abstract][Full Text] [Related]
12. Brain dopamine and serotonin transporter binding are associated with visual attention bias for food in lean men. Koopman KE; Roefs A; Elbers DC; Fliers E; Booij J; Serlie MJ; la Fleur SE Psychol Med; 2016 Jun; 46(8):1707-17. PubMed ID: 26984412 [TBL] [Abstract][Full Text] [Related]
13. Association of central serotonin transporter availability and body mass index in healthy Europeans. Hesse S; van de Giessen E; Zientek F; Petroff D; Winter K; Dickson JC; Tossici-Bolt L; Sera T; Asenbaum S; Darcourt J; Akdemir UO; Knudsen GM; Nobili F; Pagani M; Vander Borght T; Van Laere K; Varrone A; Tatsch K; Sabri O; Booij J Eur Neuropsychopharmacol; 2014 Aug; 24(8):1240-7. PubMed ID: 24976619 [TBL] [Abstract][Full Text] [Related]
14. Correlation between the availability of dopamine transporter and olfactory function in healthy subjects. Pak K; Kim K; Lee MJ; Lee JM; Kim BS; Kim SJ; Kim IJ Eur Radiol; 2018 Apr; 28(4):1756-1760. PubMed ID: 29164380 [TBL] [Abstract][Full Text] [Related]
15. Lower availability of midbrain serotonin transporter between healthy subjects with and without a family history of major depressive disorder - a preliminary two-ligand SPECT study. Hsieh PC; Chen KC; Yeh TL; Lee IH; Chen PS; Yao WJ; Chiu NT; Chen CC; Liao MH; Yang YK Eur Psychiatry; 2014 Sep; 29(7):414-8. PubMed ID: 24439516 [TBL] [Abstract][Full Text] [Related]
16. Availability of dopamine and serotonin transporters in opioid-dependent users--a two-isotope SPECT study. Yeh TL; Chen KC; Lin SH; Lee IH; Chen PS; Yao WJ; Lee SY; Yang YK; Lu RB; Liao MH; Chiu NT Psychopharmacology (Berl); 2012 Mar; 220(1):55-64. PubMed ID: 21881874 [TBL] [Abstract][Full Text] [Related]
17. Serotonin transporter and dopamine transporter imaging in the canine brain. Peremans K; Goethals I; De Vos F; Dobbeleir A; Ham H; Van Bree H; Van Heeringen C; Audenaert K Nucl Med Biol; 2006 Oct; 33(7):907-13. PubMed ID: 17045171 [TBL] [Abstract][Full Text] [Related]
18. Serotonin and dopamine transporter availabilities correlate with the loudness dependence of auditory evoked potentials in patients with obsessive-compulsive disorder. Pogarell O; Tatsch K; Juckel G; Hamann C; Mulert C; Pöpperl G; Folkerts M; Choukèr M; Riedel M; Zaudig M; Möller HJ; Hegerl U Neuropsychopharmacology; 2004 Oct; 29(10):1910-7. PubMed ID: 15292904 [TBL] [Abstract][Full Text] [Related]
19. Voxel-based analysis of age and gender effects on striatal [ Shigemoto Y; Matsuda H; Kimura Y; Chiba E; Ohnishi M; Nakaya M; Maikusa N; Ogawa M; Mukai Y; Takahashi Y; Sako K; Toyama H; Inui Y; Taki Y; Nagayama H; Ono K; Kono A; Sekiguchi K; Hirano S; Sato N Ann Nucl Med; 2022 May; 36(5):460-467. PubMed ID: 35174441 [TBL] [Abstract][Full Text] [Related]
20. Serotonin transporter binding and anxiety symptoms in Parkinson's disease. Joling M; van den Heuvel OA; Berendse HW; Booij J; Vriend C J Neurol Neurosurg Psychiatry; 2018 Jan; 89(1):89-94. PubMed ID: 28899958 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]